A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity
Authors:
- Kensuke KanekoKKKensuke Kaneko
- Hiroshi NagataHNHiroshi Nagata
- Xiao-Yi YangXYXiao-Yi Yang
- Joshua GinzelJGJoshua Ginzel
- Zachary HartmanZHZachary Hartman
- Jeffrey EverittJEJeffrey Everitt
- Philip HughesPHPhilip Hughes
- Timothy HaysteadTHTimothy Haystead
- Michael MorseMMMichael Morse
- Herbert Kim LyerlyHLHerbert Kim Lyerly
- Takuya OsadaTOTakuya Osada
Open Access
Abstract
Ductal carcinoma in situ (DCIS) of the breast is often managed by lumpectomy and radiation or mastectomy, despite its indolent features. Effective non-invasive treatment strategies could reduce the morbidity of DCIS treatment. We have exploited the high heat shock protein 90 (HSP90) activity in premalignant and malignant breast disease to non-invasively detect and selectively ablate tumors using photodynamic therapy (PDT). PDT with the HSP90-targeting photosensitizer, HS201, can not only ablate invasive breast cancers (BCs) while sparing non-tumor tissue, but also induce antitumor immunity. We hypothesized that HS201-PDT would both non-invasively ablate DCIS and prevent progression to invasive BC. We tested in vitro selective uptake and photosensitivity of HS201 in DCIS cell lines compared to the non-selective parental verteporfin, and assessed in vivo antitumor efficacy in mammary fat pad and intraductal implantation models. Selective uptake of HS201 enabled treatment of intraductal lesions while minimizing toxicity to non-tumor tissue. The in vivo activity of HS201-PDT was also tested in female MMTV-neu mice prior to the development of spontaneous invasive BC. Mice aged 5 months were administered HS201, and their mammary glands were exposed to laser light. HS201-PDT delayed the emergence of invasive BC, significantly prolonged disease-free survival (DFS) (p = 0.0328) and tended to improve overall survival compared to the no-treatment control (p = 0.0872). Systemic administration of anti-PD-L1 was combined with HS201-PDT and was tested in a more aggressive spontaneous tumor model, HER2delta16 transgenic mice. A single PDT dose combined with anti-PD-L1 improved DFS compared to the no-treatment control, which was significantly improved with repetitive HS201-PDT given with anti-PD-L1 (p = 0.0319). In conclusion, a non-invasive, skin- and tissue-sparing PDT strategy in combination with anti-PD-L1 antibodies effectively prevented malignant progression of DCIS to invasive BC. This non-invasive treatment strategy of DCIS may be safe and effective, while providing an option to reduce the morbidity of current conventional treatment for patients with DCIS. Clinical testing of HS201 is currently underway.Keywords
Funding Information
- U.S. Department of War (BC111085)
This publication has 40 references indexed in Scilit:
- Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancerBreast Cancer Research, 2012
- Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesPharmaceuticals, 2010
- An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situBreast Cancer Research, 2009
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- The natural history of ductal carcinoma in situ of the breast: a reviewBreast Cancer Research and Treatment, 2005
- The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐upCancer, 2005
- Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsyCancer, 2005
- The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breastCancer, 2004
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Photodynamic Therapy in Oncology: Mechanisms and Clinical UseJNCI: Journal of the National Cancer Institute, 1993